ArticleCell death & disease2026

RHBDL2 drives lipid metabolic reprogramming in osteosarcoma via USP3-mediated deubiquitination of PPT1.

Li Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.